A Trial Investigating the Pharmacodynamic Properties of NN1250 in Subjects With Type 1 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 08 Dec 2011 Results presented at the 21st World Diabetes Congress.
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.